Insulet to Speak at 2024 Jefferies Global Healthcare Conference

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® product line, has announced that the company will present at the Jefferies Global Healthcare Conference in New York City. The presentation is scheduled for Thursday, June 6, 2024, at 9:00 a.m. Eastern Time. Interested parties can listen to the live audio webcast of the presentation by visiting the company's investor relations website. A replay of the webcast will be available after the event.

About Insulet Corporation

Headquartered in Massachusetts, Insulet Corporation is a pioneering medical device company focused on simplifying diabetes management and enhancing quality of life through its Omnipod product platform. The Omnipod Insulin Management System offers a novel alternative to traditional insulin delivery methods. The system features a tubeless, wearable disposable Pod that provides continuous insulin delivery for up to three days, eliminating the need for users to see or handle needles.

Insulet's flagship product, the Omnipod 5 Automated Insulin Delivery System, represents the forefront of diabetes management technology. This innovative system is a tubeless, automated insulin delivery solution that integrates seamlessly with a continuous glucose monitor. It manages blood glucose levels without requiring multiple daily injections or fingersticks. Users can control the system via a compatible personal smartphone or the Omnipod 5 Controller.

Beyond insulin delivery, Insulet is leveraging its proprietary Pod technology for the subcutaneous delivery of non-insulin drugs, expanding its therapeutic applications across various medical fields.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!